Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Letter to the Editor re: Nexus of Cancer & Alzheimer's.

Carrillo MC, Fillit H, Ganguli M, Knopman D, Shineman D, Snyder HM.

Alzheimers Dement. 2017 Jun;13(6):722. doi: 10.1016/j.jalz.2017.03.006. Epub 2017 Apr 19. No abstract available.

PMID:
28431218
2.

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.

Snyder HM, Ahles T, Calderwood S, Carrillo MC, Chen H, Chang CH, Craft S, De Jager P, Driver JA, Fillit H, Knopman D, Lotze M, Tierney MC, Petanceska S, Saykin A, Seshadri S, Shineman D, Ganguli M.

Alzheimers Dement. 2017 Mar;13(3):267-273. doi: 10.1016/j.jalz.2016.11.002. Epub 2016 Dec 18. Review.

3.
4.

Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

Cheung KH, Shineman D, Müller M, Cárdenas C, Mei L, Yang J, Tomita T, Iwatsubo T, Lee VM, Foskett JK.

Neuron. 2008 Jun 26;58(6):871-83. doi: 10.1016/j.neuron.2008.04.015.

5.

Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.

Sung S, Yang H, Uryu K, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VM, Praticò D.

Am J Pathol. 2004 Dec;165(6):2197-206.

6.

Molecular determinants of heritable vitamin E deficiency.

Morley S, Panagabko C, Shineman D, Mani B, Stocker A, Atkinson J, Manor D.

Biochemistry. 2004 Apr 13;43(14):4143-9.

PMID:
15065857

Supplemental Content

Loading ...
Support Center